Posted On: 11/03/2015 11:21:05 PM
Post# of 94
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
NNRX~ Prostate cancer may have met it's match with GenEpic.
60 clinical trial patients enrolled with initial diagnosis of moderate to severe prostate cancer, and all but four showed virtually no sign of active cancer at the end of the trial period. Available today at: http://nutranomics.com/supplements/genepic.html
Study results available here: http://ow.ly/TB9kN
?#?GenEpic? ?#?Nutranomics? ?#?NNRX?
60 clinical trial patients enrolled with initial diagnosis of moderate to severe prostate cancer, and all but four showed virtually no sign of active cancer at the end of the trial period. Available today at: http://nutranomics.com/supplements/genepic.html
Study results available here: http://ow.ly/TB9kN
?#?GenEpic? ?#?Nutranomics? ?#?NNRX?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)